206 related articles for article (PubMed ID: 12818256)
1. Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry.
Ramström S; Rånby M; Lindahl TL
Thromb Res; 2003 Mar; 109(5-6):315-22. PubMed ID: 12818256
[TBL] [Abstract][Full Text] [Related]
2. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
3. The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation.
Nylander S; Mattsson C; Ramström S; Lindahl TL
Thromb Res; 2003; 111(1-2):65-73. PubMed ID: 14644082
[TBL] [Abstract][Full Text] [Related]
4. Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.
Turner NA; Moake JL; McIntire LV
Blood; 2001 Dec; 98(12):3340-5. PubMed ID: 11719372
[TBL] [Abstract][Full Text] [Related]
5. Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation.
Nylander S; Mattsson C; Ramström S; Lindahl TL
Br J Pharmacol; 2004 Aug; 142(8):1325-31. PubMed ID: 15265806
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model.
Wang K; Zhou X; Zhou Z; Tarakji K; Carneiro M; Penn MS; Murray D; Klein A; Humphries RG; Turner J; Thomas JD; Topol EJ; Lincoff AM
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):357-62. PubMed ID: 12588784
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1.
Fox SC; Behan MW; Heptinstall S
Cell Calcium; 2004 Jan; 35(1):39-46. PubMed ID: 14670370
[TBL] [Abstract][Full Text] [Related]
9. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
10. Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets.
Jagroop IA; Burnstock G; Mikhailidis DP
Platelets; 2003 Feb; 14(1):15-20. PubMed ID: 12623443
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.
Storey RF; Wilcox RG; Heptinstall S
Platelets; 2002 Nov; 13(7):407-13. PubMed ID: 12487788
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.
Cattaneo M; Lecchi A
J Thromb Haemost; 2007 Mar; 5(3):577-82. PubMed ID: 17155953
[TBL] [Abstract][Full Text] [Related]
13. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
Storey RF; Newby LJ; Heptinstall S
Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
[TBL] [Abstract][Full Text] [Related]
14. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
Roger S; Pawlowski M; Habib A; Jandrot-Perrus M; Rosa JP; Bryckaert M
FEBS Lett; 2004 Jan; 556(1-3):227-35. PubMed ID: 14706855
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
16. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood.
Remijn JA; Wu YP; Jeninga EH; IJsseldijk MJ; van Willigen G; de Groot PG; Sixma JJ; Nurden AT; Nurden P
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):686-91. PubMed ID: 11950711
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
Chaudhary PK; Kim S
J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187
[TBL] [Abstract][Full Text] [Related]
18. Platelet collagen receptor integrin alpha2beta1 activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change.
Jung SM; Moroi M
Eur J Biochem; 2001 Jun; 268(12):3513-22. PubMed ID: 11422381
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin.
Storey RF; Judge HM; Wilcox RG; Heptinstall S
Thromb Haemost; 2002 Sep; 88(3):488-94. PubMed ID: 12353080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
